Sglt-2 Inhibitors And Glp-1 Receptor Agonists For Nephroprotection And Cardioprotection In Patients With Diabetes Mellitus And Chronic Kidney Disease. A Consensus Statement By The Eureca-M And The Diabesity Working Groups Of The Era-Edta (Vol 34, Pg 208, 2019)
NEPHROLOGY DIALYSIS TRANSPLANTATION（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined